- Home
- CPB vs RADX Comparison
CPB vs RADX Comparison
Compare CPB & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPB
- RADX
- Stock Information
- Founded
- CPB 1869
- RADX 2021
- Country
- CPB United States
- RADX Australia
- Employees
- CPB 14400
- RADX N/A
- Industry
- CPB Packaged Foods
- RADX
- Sector
- CPB Consumer Staples
- RADX
- Exchange
- CPB Nasdaq
- RADX NYSE
- Market Cap
- CPB 12.1B
- RADX 11.4B
- IPO Year
- CPB N/A
- RADX N/A
- Fundamental
- Price
- CPB $40.59
- RADX $4.68
- Analyst Decision
- CPB Hold
- RADX
- Analyst Count
- CPB 14
- RADX 0
- Target Price
- CPB $49.92
- RADX N/A
- AVG Volume (30 Days)
- CPB 2.9M
- RADX 35.6K
- Earning Date
- CPB 03-05-2025
- RADX 02-26-2025
- Dividend Yield
- CPB 3.82%
- RADX N/A
- EPS Growth
- CPB N/A
- RADX N/A
- EPS
- CPB 1.83
- RADX N/A
- Revenue
- CPB $9,890,000,000.00
- RADX $1,306,729.00
- Revenue This Year
- CPB $10.05
- RADX N/A
- Revenue Next Year
- CPB $0.08
- RADX N/A
- P/E Ratio
- CPB $22.26
- RADX N/A
- Revenue Growth
- CPB 6.34
- RADX N/A
- 52 Week Low
- CPB $36.92
- RADX $3.55
- 52 Week High
- CPB $52.81
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- CPB 61.94
- RADX N/A
- Support Level
- CPB $37.91
- RADX N/A
- Resistance Level
- CPB $39.19
- RADX N/A
- Average True Range (ATR)
- CPB 0.81
- RADX 0.00
- MACD
- CPB 0.37
- RADX 0.00
- Stochastic Oscillator
- CPB 89.08
- RADX 0.00
About CPB Campbell Soup Company
Over the past 150-plus years, Campbell has evolved into a leading packaged food manufacturer in North America, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2024, snacks accounted for nearly half of its revenue, followed by soup (28%), other simple meals (17%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (a deal that closed in March 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.